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There is ample evidence identifying lead, methylmercury, and polychlorinated biphenyls (PCBs) as
neurotoxic agents. A large body of data on the neurotoxicity of lead, based on both epidemiologic
studies in children and animal models of developmental exposure, reveals that body burdens of lead
typical of people in industrialized environments produce behavioral impairment. Methylmercury
was identified as a neurotoxicant in both adults and the developing organism based on episodes
of human poisoning; these effects have been replicated and extended in animals. High-dose PCB
exposure was recognized as a developmental toxicant as a result of several episodes of contami-
nation of cooking oil. The threshold for PCB neurotoxicity in humans is less clear, although
research in animals suggests that relatively low-level exposure produces behavioral impairment
and other toxic effects. Tissue levels in fish below which human health would not be adversely
affected were estimated for methylmercury and PCBs based on calculated reference doses
(RfDs) and estimated fish intake. Present levels in fish tissue in the Great Lakes exceed these
levels for both neurotoxicants. Great Lakes fish and water do not pose a particular hazard for
increased lead intake. However, the fact that the present human body burden is in a range at
which functional deficits are probable suggests that efforts should be made to eliminate point
sources of lead contamination in the Great Lakes basin. Environ Health Perspect 103(Suppl
9):71-87 (1995)
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Introduction
There are a number of contaminants in
the Great Lakes that are neurotoxic or
potentially so. There is a large database
from the animal literature and human epi-
demiologic studies on two of these, lead
and methylmercury. The database is less
complete for a third class ofcontaminants,
polychlorinated biphenyls (PCBs). While
it is reasonably certain that PCBs are neu-
rotoxic, there are fewer human studies
upon which to determine a no observed
adverse effect level (NOAEL) or lowest
observed adverse effect level (LOAEL) than
methylmercury, PCBs, behavioral deficits
for lead or methylmercury. For most other
Great Lakes contaminants, data regarding
neurotoxicity are lacking, or levels to which
the population is exposed are not consid-
ered cause for concern. For example, there
is reason to be concerned about substances
such as toxaphene, hexachlorobenzene
(HCB), and hexachlorocyclohexanes
(HCHs) based on their chemical structure,
but neurotoxicity data are almost nonexis-
tent. Other agents known to be neurotoxic,
such as organotin compounds and various
pesticides, are found in the Great Lakes
basin at levels that are orders ofmagnitude
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lower than those that have even been tested
in animals or at which neurotoxicity has
occurred in humans. Therefore, discussion
of neurotoxicity is restricted to lead,
methylmercury, and PCBs.
Lead has been known to be neurotoxic
since ancient times. As a result ofhuman
activity, the present body burden oflead is
2 to 3 orders of magnitude above back-
ground levels. In the last 15 years, it has
become clear that exposure to lead in utero
or during childhood at body burdens that
are presently typical ofhumans in industri-
alized countries results in deficits in intelli-
gence quotient (IQ) and in other behavioral
problems. Approximately 20 epidemiologic
studies, both prospective and retrospective,
provide extremely strong and consistent
evidence. A large body ofanimal data indi-
cates that lead produces behavioral impair-
ment and is also consistent with respect to
the types of impairment observed in chil-
dren. It is also becoming increasingly clear
that there is no apparent threshold for
these effects at present day body burdens.
Moreover, the generation ofwomen exposed
to the most lead since ancient times is
presently at reproductive age and will pro-
vide a significant source of in utero lead
exposure via bone stores. The most signi-
ficant sources of lead exposure are food
(indirectly from environmental fallout) and
water via lead or lead-soldered plumbing.
The Great Lakes basin does not present a
particular hazard with regard to lead expo-
sure; however, given that there is no
identified threshold for behavioral impair-
ment produced by lead in the developing
organism, every effort should be made to
eliminate any industrial sources oflead from
the Great Lakes basin.
Methylmercury was recognized as a
neurotoxic agent following outbreaks of
human poisoning through contaminated
fish in Japan in the 1950s and 1960s.
Later episodes ofhuman poisoning in Iraq
due to ingestion of grain treated with an
organomercury fungicide provided an
excellent database for neurotoxic effects,
including detailed estimates of thresholds
for various end points. It is clear that the
fetus is much more sensitive than the
adult. The most sensitive end points
identified to date are developmental delays
in children exposed in utero. A reasonably
good animal database exists that replicates
the types of neurotoxicity observed in
humans. Consumption of contaminated
fish represents the most important source
Environmental Health Perspectives - Vol 103, Supplement 9 - December 995 71D.C. RICE
of exposure to methylmercury. Reference
doses (RfDs) based on developmental neu-
rotoxicity in humans in the Iraqi episode
are in the range of0.06 to 0.07 pig/kg/day.
Similar estimates based on the available
animal data, particularly from monkeys,
suggest an RfD of0.05 pg/kg/day. The lev-
els of methylmercury observed in Great
Lakes fish represent a potential hazard to
offspring of women who consume large
quantities of fish. Further studies, includ-
ing ongoing prospective epidemiologic
studies, should serve to refine levels at
which toxicity is known to occur.
It is certain that high doses of PCBs
produce reproductive toxicity in humans.
Two well-designed prospective epidemio-
logic studies in humans provide evidence
for behavioral deficits associated with low-
level in utero exposure to PCBs. In one
study, exposure was via contaminated
Great Lakes fish and, in the other study,
there was no identified source ofexposure.
A possible limitation ofthese studies, par-
ticularly the former, is failure to assess and
control for other potential neurotoxicants
such as methylmercury that are potentially
correlated with PCB level. However, there
is a significant body ofdata from monkeys
inwhich behavioral deficits were observed as
a result ofdevelopmental exposure to PCBs.
Developmental and neurotoxic effects have
also been confirmed in other animal models.
The most significant source of PCB expo-
sure in the general population is contami-
nated fish. RfDs promulgated by a number
ofstate and Federal agencies in the United
States are 0.05 pg/kg/day or lower, based on
data from both animal and human develop-
mental studies. Women who are frequent
consumers ofGreat Lakes fish would exceed
this number byasignificant amount.
Lead
Lead has been recognized as a poison from
ancient times to the present (1,2). Recently,
attention has focused on the subtle effects of
environmental exposure at levels presently
considered normal in our industrialized age
(3-8). The recognition that lead produces
intellectual impairment in children, as well
as other health effects, has resulted in the
progressive tightening ofthe regulation of
the uses oflead in the United States and
other countries, including the phaseout of
lead from gasoline (9), a decrease in the
amount oflead allowable in drinkingwater,
and abatement of lead from buildings
contaminated with lead paint.
Although lead is a common element in
the earth's crust, its ubiquitous presence in
bioavailable forms in the environment is
due largely to the activities of humans
(10,11). The industrial revolution and the
addition oflead to gasoline in the 1920s
have resulted in dramatic increases in envi-
ronmental lead levels (12,13). Present
environmental levels are estimated to be
several orders of magnitude above prein-
dustrial levels (Table 1) (14). The body
burden of lead in human bones is
presently 500-fold greater than in prehis-
toric times, and the present-day diet of
Americans contains 100 times more lead
than prehistoric diets (14).
In the 1940s itwas recognized by astute
physicians that children who had been
treated for lead poisoning suffered perma-
nent neurologic damage including poor
school performance, impulsive behavior,
short attention span, restlessness, and occa-
sional neurologic signs (15). High-level
lead exposure in children at that time was
caused by lead-based paint. These observa-
tions were later replicated by other investi-
gators (16-18). Early in the 1970s, deficits
in IQ, fine motor performance, and behav-
ioral disorders such as distractibility and
constant need for attention were observed
in children who had never exhibited overt
signs oflead intoxication (19,20). Concern
arose in the United States and elsewhere
that the manytons oflead being introduced
into the environment every year by the use
ofleaded gasoline, as well as other indus-
trial processes, were producing significant
health effects, particularly in children. A
new understanding ofthe insidious effects
oflead on the intellectual capacity ofa large
number ofchildren arose in 1979 with the
landmark study ofNeedleman et al. (21).
These investigators reported decreased IQ
and increased incidence ofdistractibility
and inattention in middle-class children
with no exposure to lead from paint.
Largely as a result ofthe Needleman et
al. study (21), there has been intense
research into the health effects oflead and
on the sources of exposure to the general
population over the last 15 years. The issue
has generated a great deal of political as
well as scientific controversy. The result of
this intense scrutiny is that probably more
is known about the health effects oflead
than about any other noncarcinogenic envi-
ronmental contaminant. The result in the
United States has been a rapid decrease over
the last two decades by the Centers for
Disease Control and Prevention (CDC) in
the blood level considered to be safe for
children to a present level of10 pg/dl (22).
EpidemiologicStudies
There have been several recent reviews on
the neurobehavioral effects oflow-level lead
exposure in children, including metaanaly-
ses (23-25) and a discussion on method-
ological issues critical to interpretation of
the literature (26). These studies have con-
sistently concluded that an increased body
burden oflead in children is associated with
a decrease in IQ. Schwartz (23) found that
the association between lead exposure and
children's IQ remained strong even with
the inclusion or exclusion ofthe strongest
individual studies; moreover, he concluded
that there was no evidence of a threshold
down to blood lead concentrations as low
as 1 pg/dl. This paper is not a definitive
review ofthe epidemiologic literature but
rather an overview of the types ofeffects
that have been observed and the body
burden atwhich they occur.
Cross-sectional Studies
There have been a number of cross-sec-
tional (retrospective) studies since 1979
concerning the effects oflead on intellectual
and behavioral functions in children. The
general trend has been to study children
with increasingly lower body burdens of
lead and to focus on middle-class rather
than disadvantaged children. These studies
Table 1. Comparison ofestimated natural levels of lead in the environmentwith typical present-day levels.
Estimated natural lead Typical present-day Approximate ratio,
Medium concentrations lead concentrations present-day/natural
Air
Rural/remote 0.01-0.1 ng/m3 0.1-100ng/m3 10-1,000
Inhabited 0.1-1.0 ng/m3 0.1-10 pg/M3 100-10,000
Soil
Rural/remote 5-25 pg/g 5-50 pg/g 1-2
Inhabited 5-25 pg/g 10-5,000 pg/g 2-200
Water
Fresh 0.005-10 pg/I 0.005-10 pg/I 1
Ocean 0.001 pg/I 0.005-0.015pg/l 10
Foods 0.0001-0.1 pg/g 0.01-10 pg/g 100
From the National Academy ofSciences, Committee on Lead in the Human Environment(14).
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have been extensively reviewed (5,7,27).
Such studies have usually included some
measure of intelligence (IQ), school func-
tioning, teachers' rating ofclassroom behav-
ior, or specific measures of attentional
mechanisms. Fulton et al. (28) reported a
linear relationship between intellectual
functioning and log blood lead concentra-
tion for blood lead values between about 5
and 25 pg/dl (mean about 10 pg/dl) in
children living in Edinburgh, Scotland,
with no indication ofa threshold for lead
effect (Figure 1). Results were significant
after adjusting for potential confounders.
In a study in Denmark, children with aver-
age blood lead levels of 5.7 ,ug/dl were
impaired in comparison to children with
blood lead levels of3.7 pg/dl (29). A num-
ber ofother studies published since 1980
have also reported an association between
increased lead body burden and poorer
cognitive performance (30-41). Needleman
et al. (42) reported dose-dependent disor-
dered classroom behavior as measured by a
teacher's rating scale, which was subse-
quently replicated by others (33,39,43).
High-lead children also exhibited more
deviant performance on tests ofconduct
problems, inattentive-passive, and hyper-
activity scales (39,43). A study ofmiddle-
class children in New Zealand also reported
high correlations between log blood lead
(mean=11 pg/dl) and measures ofinatten-
tion and hyperactivity after adjusting for
confounding variables (44). Such early
attentional deficits and their associate
behaviors place children at risk for acade-
mic failure and behavior problems (45). It
is therefore not surprising that early
increased lead levels resulted in increased
grade retention or need for special educa-
tion. In a follow-up of the children from
the Needleman et al. 1979 study (42),
tooth lead levels in 5- and 6-year olds pre-
dicted an increase in grade retention and a
2-fold increase in the need for academic aid
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Figure 1. British Ability Scales Combined (BASC) Score
(mean and 95% confidence interval) as a function of log
blood lead levels in 6- to9-year-old children in Edinburgh,
Scotland. Adjusted forcovariates. From Fulton etal.(28).
incidence of dropping out ofhigh school
and having deficits on various performance
measures (47). Barrett (48) reported a
dose-related increase in unsatisfactory
school performance as a function of
increased free erythrocyte protoporphyrin
(FEP) levels (a measure oflead exposure).
Lead is associatedwith increased reaction
time and increased errors on various perfor-
mance and vigilance tasks (32,37,40,41,49).
Using the National Health and Nutrition
Examination Survey II (NHANES II) data-
base, Schwartz and colleagues (50) found
an association between lead and increased
hearing threshold in children with blood
levels between 5 and 45 pg/dl, with no
threshold for effect; they also found slowed
nerve conduction velocity at blood lead
levels above 20 to 30 pg/dl (51). Blood
lead levels of 15 pg/dl and below are also
associated with changes in electroen-
cephalogram (EEG) pattern and auditory
evoked potentials (52,53).
Prospective Studies
There are a number ofprospective studies
examining the developmental effects of
environmental lead exposure in which a
large body ofdata has been collected over a
number of years. The mothers were
recruited before the birth oftheir infants,
and the infants followed in a longitudinal
manner. This design is stronger than a
cross-sectional design, and these studies
have provided convincing data regarding
developmental deficits produced by low-
level lead exposure (23,24,27,54-56).
In a study by Bellinger and colleagues
(57), performance on the Bayley Mental
Development Index (MDI) at 6, 12, and
24 months ofage was associated with cord
but not postnatal blood lead levels. The
difference between the high (mean=14.6
pg/dl) and low (mean=1.8 pg/dl) blood
lead groups was 4 to 7 points. Assessment
ofthese children at 57 months ofage (58)
revealed that performance on the General
Cognitive Index of the McCarthy Scales
was associated with blood lead levels at 24
but not 57 months ofage, after adjusting
for possible confounders. Blood level val-
ues averaged 6.8 pig/dl at 24 months and
6.4 jtg/dl at 57 months. These children
were evaluated for school dysfunction at 8
years of age (59); umbilical cord blood
level >10 pg/dl was associated with prob-
lems in both sexes, although the pattern
differed between boys and girls. When
these children were retested at 10 years of
age, a 10-pig/dI increase in blood lead at 24
months was associated with a 5.8-point
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Figure 2. Mean (±SE) adjusted WISC-R Full-Scale 10
scores and the Kaufman Test of Educational
Achievement-Brief form (K-TEA) in 10 year-old chil-
dren classified by blood lead levels at 24 months of
age. From Bellinger et al. (60).
decline on full-scale IQ on the Wechsler
Intelligence Scales for Children-Revised
(WISC-R) and an 8.9-point decline on the
Kaufman Test ofEducational Achievement
(Figure 2) (60). Recent blood lead levels
were associated with perseverative behavior
on the Wisconsin Card Sorting Test, a test
ofabstract thinking, sustained attention, and
ability to change response strategy accord-
ing to environmental requirements (61).
In a study by Dietrich and colleagues
(62,63), it was found that each log unit
increment in blood lead (mean at birth =
4.5 pg/dl) was associated with a covariate-
adjusted reduction of 5.7 points on the
MDI at 6 months ofage; the reduction was
8.0 points if the effect on gestational age
and birth weight were included. At 1 year
after birth, prenatal blood lead levels were
negatively correlated with MDI, Bayley
Psychomotor Development Index (PDI),
and Bayley Infant Behavioral Record
(IBR). The IBR revealed higher activity
levels and more negative social-emotional
response. These effects appeared to have
attenuated in this group ofdisadvantaged
children by 4 years ofage (64), although
prenatal and postnatal blood lead levels
were negatively associated with auditory
processing ability in these children at 5
years of age (65). When these children
were reassessed at 6.5 years ofage, lifetime
blood lead concentration in excess of
20 pg/dl was associated with a 7-point
decrease in performance IQon the WISC-
R compared to children with blood lead
levels less than 10 pg/dl (Figure 3) (66).
In a third prospective study in Port
Pirie, SouthAustralia (67-69), a decrease of
2 points in the MDI scale for every 10-pig/dl
increase in blood lead levels was observed at
24 months ofage. Performance was found
to be more related to postnatal than prenatal
blood lead levels; however, no assessment







* Adjusted p <0.05
1 2 3 4
0-10 >10-15 >15-20 >20
Average lifetime blood lead groups
Figure 3. Adjusted and unadjusted relationship
between average lifetime blood lead and WISC-R
performance IQ in 6.5 year-old children. From Dietrich
et al. (66).
was performed before 2 years ofage. It is
possible that early testing would have
revealed significant prenatal exposure
effects. In a follow-up assessment (70), pre-
vious blood lead levels were found to be
inversely correlated with performance on
the McCarthy Scales ofChildren's Abilities
at 4 years ofage. Subjects with blood lead
levels of30 pg/dl had a general cognitive
score 7.2 points lower than children with
blood lead levels of 10 pg/dl; there was no
evidence of a threshold for effect. These
deficits persisted to 7 years ofage, with a 4
to 5 point drop in IQ for blood levels
between 10 and 30 pg/dl (71).
Recent studies provide evidence that
low-level lead exposure also causes reproduc-
tive problems per se. Maternal blood lead
levels are associated with increased incidence
ofpreterm delivery (68) and decreased ges-
tational age (62,72), although this has not
been a consistent finding (73,74). Increased
blood lead has also been found to be asso-
ciated with increased spontaneous abortion
(68). Higher lead burden may also be asso-
ciated with minor but not major physical
abnormalities (75), although this is not a
universal finding (68,76). Maternal blood
lead level is also associated with abnormal
reflexes, poor muscle tone, and neurologic
soft signs such asjitteriness, hypersensitivity,
and abnormal cry in the infant (76,77). It
must be stressed that the maternal and
infant blood lead levels in these studies were
in the range considered normal or average
for people in industrialized societies (in the
range of2-15 pig/dl in most cases). It is well
established that premature or small-for-date
infants are at greater risk for a variety of
behavioral and other health problems. Such
children have more trouble in school and
require special help more often than other
children (78,79). The effects of lead on
intellectual functioning may at least in part
be a consequence ofits effects on reproduc-
tive outcome. In fact, controlling for effects
such as gestational age in evaluation of




The positive results obtained in the prospec-
tive studies deserve attention in a different
vein. The implication ofthe findings is that
the lead body burden ofwomen, reflected
by maternal and cord blood lead levels, is
important to at least the early well-being of
children. The women and their offspring
described in these studies had blood lead
levels that are typical in our present envi-
ronment-the result ofsimply living in a
present-day industrialized society. One
important unanswered (and unaddressed)
question is the contribution oftotal mater-
nal bodyburden, rather than blood level, to
the risk to the infant. Bone, containing over
90% oflead stores, is the most significant
compartment for lead storage in the body,
and it is established that lead increases in
bone throughout the lifespan ofhumans
(80). Since a large portion ofwomen are
now delaying childbearing until relatively
late, it may be that they are exposing their
fetuses to an increased burden oflead as a
result ofmobilization from bone. The cal-
cium turnover from bone is increased dur-
ing pregnancy and lactation, and there is
some evidence that bone lead may be mobi-
lized as well as a result ofpregnancy and lac-
tation long after exposure has ceased (81).
The amount oflead in milk in humans is
correlated with people having lived in a
high-traffic area for at least 5 years regard-
less ofwhether this occurred during child-
hood or adulthood (82). Since women who
were born in the 1950s and 1960s will have
in general a significantly higher total body
burden oflead than previous generations
due largely to indirect exposure resulting
from leaded gasoline, this represents a
potentially important problem for years to
come, despite the fact that the concentra-
tion oflead in the general environment is
presently decreasing.
Animal Data
The animal data on the behavioral effects of
developmental lead exposure are remarkably
conciient with the human data, both in
terms of the types of behavioral deficits
observed and the blood levels atwhich they
occur. It has been established for some
time that developmental lead exposure pro-
duces behavioral impairment in animals
(83). Initial studies using simple learning
tasks in rats exposed prenatally plus post-
natally usually produced positive results on
simple discrimination problems (84-86).
Difficult problems were more sensitive to
disruption by developmental lead exposure
in rats (87) and sheep (88).
An extensive body ofdata has been col-
lected over the last decade and a halfon the
behavioral effects oflead in animal models
[for reviews, see Rice (89-91), Davis et al.
(92)]. Reproducible robust deficits in learn-
ing and short-term memory have been
demonstrated on a variety of behavioral
tasks as a result ofdevelopmental lead expo-
sure in two different species ofmonkeys in
two laboratories, one at the University of
Wisconsin and the other at the Health
Protection Branch in Canada. Research per-
formed at the University of Rochester in
which rats were dosed beginning postwean-
ing has also demonstrated impairment of
learning ability. In the monkey, behavioral
deficits have been observed consistently on a
number oftasks in four cohorts ofmonkeys
dosed with lead from birth onward; the
lowest dosed cohort had blood lead levels
during infancy of 15 pg/dl and steady-
state blood lead levels of 11 ig/dl. Deficits
were observed from the juvenile period,
when testing began, through adulthood.
Permanent deficits have also been observed
in a number ofcohorts dosed early in life
(prenatally or postnatally until approxi-
mately 1 year ofage) and tested at various
ages-as long as 6 to 8 years after cessation
oflead exposure. In no study in either the
rat or the monkey was a no-effect dose
identified. The present section provides an
overview ofthe types ofdeficits observed in
animal models in relation to congruence
with the epidemiologic data.
The types of behavioral tasks used to
assess lead-induced impairment included
intermittent schedules of reinforcement,
spatial and nonspatial discrimination
reversal with and without irrelevant stim-
uli, spatial delayed alternation, spatial and
nonspatial delayed matching to sample,
repeated acquisition, and sequential and
concurrent visual discrimination (90,91).
Functions assessed by these tasks include
learning, memory, and attentional processes.
Impairment on a number ofthese tasks has
been observed in different groups and
species ofanimals in different laboratories.
Detailed assessment ofperformance such as
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analysis oferror pattern revealed persever-
ation, increased distractibility, inability to
inhibit inappropriate responding, and
difficulty in changing response strategy as
behavioral deficits underlying the poorerper-
formance oflead-treated animals (89,91).
These findings are similar to those reported
in children in terms ofbehavioral functions
impaired by lead; short attention span,
increased distractibility, and impulsivity
have been identified by teacher's and par-
ent's rating scales as being consequences of
increased body burdens of lead, while
impairment on vigilence tasks and increased
simple reaction time suggests impairment
in attentional processes.
A specific example of an analogous
impairment between lead-exposed mon-
keys and children is the discrimination
reversal paradigm in monkeys and the
Wisconsin Card Sort Test in children. In
the nonspatial version of the discrimina-
tion reversal task, the monkey was pre-
sented with two stimuli that varied in one
or more ways (i.e., form, shape, color, posi-
tion) (93). The monkey was required to
respond to a specified stimulus (e.g., always
choose the red rather than the green, irre-
spective ofposition or shape) in order to be
rewarded with a preferred food or juice.
When the monkey learned the task to a
predetermined criterion, the rule was
changed (reversed) so that the previously
incorrect stimulus became the correct one
(e.g., green rather than red). A number of
such reversals were instituted; normal
monkeys learn each successive reversal
more quickly, displaying a learning curve.
Monkeys were tested on a series of three
tasks with the relevant stimulus dimension
changed between tasks; for example,
"attend to the color and ignore the shape"
was changed to "attend to the shape and
ignore the color." In addition, the last two
tasks included irrelevant stimuli ofthe for-
merly relevant stimulus class. For example,
a task requiring the monkey to attend to
shapes such as a cross and a square was fol-
lowed by a task requiring attention to color
but with the cross and squre superimposed
on the colors in a balanced design. The
inclusion of irrrelevant cues provided the
opportunity to assess distractibility (or per-
severation). This task makes similar
demands to the Wisconsin Card Sort Test
in that both require the subject to extract
general rules, to change response strategy
in response to the consequences of their
own behavior (i.e., whether a response or
set ofresponses is correct or incorrect), and
to ignore a formerly relevant stimulus
dimension. Both lead-exposed monkeys
(93) and children (61) are impaired in their
ability to adjust to the requirements, perse-
verating in response strategies that are no
longer effective. Effects were observed in
monkeys with blood lead levels of 11 pg/dl
as well as in a number of cohorts with
higher blood lead levels.
In a study on possible sensitive periods
for deleterious effects produced by lead,
monkeys were exposed to lead either con-
tinuously from birth, only during infancy,
or beginning after infancy. Lead levels were
about 30 to 35 pg/dl when monkeys were
exposed to lead and given access to infant
formula and 19 to 22 pg/dl when dosed
with lead after withdrawal of infant for-
mula (94). These monkeys were tested as
juveniles on the same nonspatial discrimi-
nation reversal tasks described above (93).
Both the group dosed continuously from
birth and the group dosed beginning after
infancy were impaired over the course ofthe
reversals in away similar to that observed in
the study discussed above, including
increased distractibility by irrelevant cues.
The higher exposure levels in this study
were reflected in impairment on all three
tasks whereas in the previous study, lead
treated monkeys were impaired on only the
first two tasks. The group exposed only dur-
ing infancywas unimpaired on these tasks.
Performance on a series of spatial dis-
crimination reversal tasks, analogous to
the nonspatial discrimination reversal tasks
already described, was assessed in this
same group ofmonkeys (95). Contrary to
the results of the nonspatial discrimination
reversal task in which the group dosed only
during infancy was unimpaired, all three
dose groups were impaired to an equal
degree. These data suggest that spatial and
nonspatial tasks may be affected differen-
tially depending on the development
period oflead exposure. Such results have
important implications for interpretation
ofthe epidemiologic literature; in particu-
lar, differential effects on various cognitive
domains may be expected within and across
studies, depending on the pattern ofblood
lead levels and the potential for sensitive
periods for various effects. For example,
impairment on the Wisconsin Sort Test
described above was linked to concurrent
blood lead levels in the children when
tested at 10 years ofage, whereas results on
standard intelligence tests best correlated
with 2-year-old blood lead levels. It may
be naive to expect that the pattern of
effects would or-should bethe same across
epidemiologic studies.
The modern body ofdata regarding the
behavioral toxicity produced by develop-
mental lead exposure in animals, which con-
sists ofseveral dozen research publications,
is consistent not only in documenting
reproducible effects on a variety ofbehav-
ioral tasks but also in identifying underlying
behavioral processes responsible for the
behavioral impairment revealed by assess-
ment ofglobal measures ofperformance.
Moreover, it may be inferred from epi-
demiologic studies that these same behav-
ioral processes are impaired in children as a
result ofincreased lead exposure (91). This
congruence between the behavioral deficits
identified in animal models and children,
as well as the similarity ofblood lead levels
at which these effects are observed, provide
strong support for the assertion that the
deficits in cognitive function observed in




The greatest source of lead for most
children is food and drinking water,
although direct inhalation also contributes
to body burden. Much ofthe lead in food
is the result of the historical fallout from
leaded gasoline, and lead in water may
result from lead or lead-soldered plumbing
or environmental contamination. In addi-
tion, exposure through flaking and peeling
lead-based paint is a significant contributor
to the lead burden ofmany children, par-
ticularly in the United States. The intake
and body burden of lead in present-day
humans is 2 to 3 orders ofmagnitude above
preindustrial levels, and there is no appar-
ent threshold for many of the behavioral
deficits observed in children. Fish from the
Great Lakes do not provide an elevated
intake of lead compared to other foods.
The Canadian Health Department guide-
line for lead in drinkingwater is 10 pg/l. In
an analysis ofwater from seven cities bor-
dering the Great Lakes, onlywater that was
collected from the distributior system,
rather than raw water samples, exceeded
this guideline (96). Data for 1990 to 1992
from the Canadian drinking water surveil-
lance program suggest that, in general, the
Canadian guideline was not exceeded by
water from treated sewage that was returned
to the Great Lakes. Plumbing contributes a
much greater amount oflead to drinking
water than a Great Lakes source, and the
Great Lakes basin does notprovide anypar-
ticular hazard that is not present in the gen-
eral environment. However, the fact that
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the present human body burden is in a
range at which functional deficits are proba-
ble suggests that all reasonable efforts should
be made to minimize point sources oflead
contamination in the Great Lakes basin.
Methylmercury
Although the toxicity of mercury com-
pounds has been recognized for centuries,
the outbreak ofmethylmercury poisoning
in the late 1950s in Minamata, Japan,
focused attention on the potential devasta-
tion of neurotoxic agents in the environ-
ment (97-100). The source ofthe exposure
was a chloralkali plant that dumped
methylmercury directly into surface water,
which was then accumulated by marine
biota, passed up the food chain to fish, and
eventually ingested by the human popula-
tion ofthe area. Thousands ofpeople were
exposed and hundreds ofpeople became
clinically ill during the years before and
shortly after the hazard was recognized. A
subsequent outbreak oforganomercury poi-
soning occurred in Iraq in 1971 to 1972
when grain treated with an organomercury
fungicide was ground for bread rather than
stored for spring planting; thousands of
people became clinically ill and hundreds
died as a result of exposure. As a conse-
quence ofthese tragic episodes, the toxicity
produced by organomercury compounds in
humans is well characterized. Effects
include mental disturbances, paresthesias,
visual deficits, disturbances ofgait, tremor,
and weakness. The fetus or nursing infant is
more sensitive to the effects ofmethylmer-
cury than the adult, and signs include
cerebral palsy and mental retardation.
The neurotoxic effects produced in
humans have been well replicated in animal
models. Methylmercury exposure in mon-
keys produces the same types ofvisual and
somatosensory deficits observed in humans.
Rodents have been used to explore the
motor deficits produced by methylmercury.
Developmental exposure results in greater
impairment than adult exposure, and the
overt neurotoxic effects observed in infant
monkeys are similar to those observed in
infant humans.
Effects in Humans
The effects ofmethylmercury toxicity in
humans are well documented and have
been extensively reviewed (97-100). In
adults in Japan, the most common com-
plaints were ofsensory and motor distur-
bances including vision, hearing, and
somatosensory dysfunction, unsteadiness of
gait and disequilibrium, muscle weakness,
and dysarthria (101). Data from human
mother-infant pairs suggest that infants are
born with higher blood mercury levels than
their mothers have (102-104). It is not
clear whether infants eliminate mercury
more slowly than their mothers (102,103)
or whether children eliminate mercury
more slowly than adults after methylmer-
cury exposure. Neonatal and in utero expo-
sures to methylmercury often result in
more severe signs ofintoxication in the off-
spring than in the mother (105-109);
signs ofintoxication include cerebral palsy,
mental retardation, and delayed walking
and speech (105-110). In a study in New
Zealand ofchildren exposed to methylmer-
cury in utero, relatively low maternal hair
mercury levels were associated with
increased deficits in motor, language, psy-
chological, scholastic, and behavioral tests
at 4 (111) and 6 (112) years ofage.
Deficits in visual function are a hall-
mark of methylmercury intoxication in
humans (113-115). In adult methylmer-
cury poisoning, the most conspicuous
finding is constriction in visual fields; how-
ever, other visual deficits have also been
reported in adults, including deficits in spa-
tial (116,117) and temporal (118,119)
visual function. Developmental exposure at
high levels may result in oculomotor mani-
festations and blindness (103,120-123),
whereas less severe poisoning may result in
changes in acuity (116) and constriction of
visual fields (106,107). The pattern of
damage produced by methylmercury in the
human visual system has been well delin-
eated, with primary visual cortex being a
major site ofdamage. In adult poisoning,
the most severe damage is in calcarine fissure
(105,124,125), which corresponds to the
peripheral visual fields. In postnatal or in
uteroexposure, however, damage is more dif-
fuse with neuronal loss in all areas ofvisual
cortex (105,126-128), as well as in many
other brain areas. Retina and optic nerve are
presumed not to be involved (118).
Hearing deficits have been frequently
observed. Frequency ofhearing deficits in
adults as a result of methylmercury poi-
soning ranges from 42 (115) to 85%
(101,110). Assessment ofpure tone detec-
tion thresholds, tested in the range ofspeech
frequencies, revealed hearing impairment in
half the ears tested (129). Severe hearing
impairment, deafness, and delayed speech
development have resulted from in utero
exposure to methylmercury (103,122,130).
Paresthesias are also frequently reported
in adults as a result of methylmercury
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Figure 4. Relationship between frequency of signs and
symptoms and the estimated body burden of
methylmercury based on data from Iraq. The two
scales on the abscissa represent different methods of
estimating total body burden. From the World Health
Organization (100).
most sensitive effect of methylmercury
exposure in adults is paresthesias (Figure 4),
with a threshold of25 to 40 mg total mer-
cury uptake. The World Health
Organization (WHO) has relied largely on
the Iraqi data in generating dose-response
relationships for toxicity associated with
methylmercury (98-100). It was estimated
that long-term daily mercury intake of3 to
7 pg/kg body weight (bw) associated with
blood mercury levels of 200 pg/l and hair
concentrations ofabout 50 pg mercury per
gram would be associated with a 5% inci-
dence of early effects in adults. Effects in
the fetus occur at maternal body burdens
considerably lower than effects in the
adult. For example, the threshold in mater-
nal hair associated with delayed walking in
the infants of exposed mothers may be
one-fifth of that necessary to produce the
earliest effects in adults (Figure 5) (100).
Anim Stu&es
Many of the effects of methylmercury
observed in humans have been replicated
and extended in animal models (132,133).
In some respects the rodent does not repre-
sent an optimum model for effects in
humans. The rodent brain does not have
the pattern of deep sulci of the human
(and monkey) brain, which are preferen-
tially damaged by methylmercury (125).
Therefore, the pattern of central nervous
system damage is different between
primates and rodents (128). This differ-
ence is reflected in differences in the pat-
tern ofneurologic, sensory, and behavioral
effects observed in rodents and primates,
including humans. Early studies in rodents
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Figure 5. Relationship between maximal maternal hair concentration of methylmercury during pregnancy and
retarded walking in the offspring. The shaded area denotes nonsimultaneous 95% confidence limits for a nonpara-
metric kernal smoothing analysis. Solid lines represent logit and hockey-stick parametric molds. From the World
Health Organization ( 100).
demonstrated motor deficits as a result of
prenatal exposure, although the pattern of
cerebral palsy and severe sensory impairment
characteristic ofhigh dose in utero exposure
in humans was not observed. In contrast,
exposure ofadult (134) or neonatal (135)
monkeys to methylmercury replicated the
pattern of sensory and motor impairment
produced in humans. The toxicokinetics of
methylmercury are also quite different
between primates and rodents. For example,
the ratio of mercury between brain and
blood following methylmercury exposure is
2 to 5 for monkeys following moderate-level
chronic exposure (136-139), which is simi-
lar to the estimates for humans (140). This
is in marked contrast to the estimated brain-
blood ratios ofthe rat (0.06), although the
estimate for the mouse is 1.2 (140).
One of the hallmarks ofmethylmercury
neurotoxicity in the adult human is deficits
in visual function as a result ofneuropatho-
logic damage to calcarine fissure. Attention
has focused on constriction ofvisual fields,
although other deficits such as impaired spa-
tial visual function have also been observed
(117). Constriction ofvisual fields has been
replicated in the adult macaque monkey
(141), which exhibits a pattern ofdamage
identical to that in the human. Other func-
tional deficits in visual function have also
been documented in adult monkeys
exposed to methylmercury. Deficits in low-
luminance form vision were detected on a
visual discrimination task; these effects pre-
ceded more global visual deficits (134).
Decrements in detection of a flickering
stimulus at low luminance have been
observed in monkeys that also demonstrated
constriction ofvisual fields (141), which
replicates effects observed in humans (119).
Decreased flicker sensitivity has also been
observed in squirrel monkeys exposed to
methylmercury (142). Monkeys in these
studies had blood mercury levels of 2.0 to
3.0 parts per million (ppm). In adult mon-
keys exposed to methylmercury, extensive
and consistent neuropathologic changes sim-
ilar to those in adult humans are observed in
visual cortex (142-146). Changes in the
optic nerve were not observed.
Since it was clear from the episodes of
human methylmercury poisoning that the
developing organism is more sensitive to the
effects ofmethylmercury intoxication than
the adult, studies at the Canadian Health
Protection Branch have assessed sensory
system function in monkeys exposed devel-
opmentally to methylmercury. One group
of five monkeys was exposed from birth to
7 years of age with 50 pg/kg/day of mer-
cury as methylmercuric chloride. Blood
total mercury levels were 0.6 to 0.9 ppm. A
second group was exposed in utero plus
postnatally to 4 years of age; maternal doses
were 10, 25, or 50 pg/kg/day, and blood
mercury levels were in equilibrium before
breeding. Maternal blood mercury levels
were 0.3 to 1.4 ppm. Five infants were born
in the highest dose groups, two at the inter-
mediate dose, and only one at the lowest
dose. Visual deficits were observed in both
groups ofmonkeys and in all dose groups
(i.e., 50, 25, or 10 pg/kg/day maternal
exposure) (147,148); treated monkeys
exhibited impaired high-frequency spatial
and low-frequency temporal vision with no
constriction ofvisual fields.
Relatively little research has been per-
formed in animals on the effects of
methylmercury on the auditory system,
and most experiments were performed in
adult animals after acute high-level expo-
sure. Damage has been observed in the
hair cells ofthe organ ofCorti (149-151).
Measurement of brain stem auditory-
evoked potentials revealed deficits across
all auditory frequencies in mice (152).
However, low-dose chronic exposure may
produce a different pattern of damage
compared to high-dose acute exposure, as
has been observed for other metals such as
lead. The monkeys exposed only postna-
tally exhibited impairment of high-fre-
quency hearing 7 years after cessation of
methylmercury exposure (153).
Indications ofdelayed neurotoxicity in
monkeys as a result of developmental
methylmercury exposure has also been
reported (154). Thirteen-year-old mon-
keys dosed postnatally to 7 years of age
(discussed above) were observed to be
clumsy and to take longer to retrieve raisins
6 years after cessation of methylmercury
exposure. Independent clinical assessment
by two veterinarians also revealed a higher
incidence of failure to respond to a light
touch or pin prick to the hands, feet, or tail
in methylmercury-exposed monkeys. In
addition, observation of these monkeys in
the large cages in which they had exercised
and socialized since infancy revealed clum-
siness in some treated individuals, a ten-
dency for the hind feet to slip down the
bars when climbing, and a preference for
climbing from area to area rather than
jumping. These monkeys had undergone
routine clinical assessment ofsensory and
motor function from infancy to about 4
years of age, with no signs of toxicity
noted. The observation ofovert toxicity at
age 13, 6 years after cessation ofdosing,
therefore represents delayed neurotoxicity
as a consequence ofmethylmercury expo-
sure. These observations were pursued
objectively by measuring vibration sensitiv-
ity in the finger tips in these monkeys
(155). Methylmercury-treated monkeys
exhibited higher sensory thresholds, which
indicated a reduced ability to detect vibra-
tion. These results are consistent with the
reports ofparesthesias in methylmercury-
exposed humans.
Effects ofdevelopmental methylmercury
exposure on intellectual function have also















been pursued in animal models. In a study
on the effects in utero exposure to
methylmercury in the monkey, females
received 50, 70, or 90 pg/kg/day of
methylmercury. The offspring from the
lowest dose group were tested on an object
permanence task beginning at 2 weeks of
age (156). This task tested the infants' abil-
ity to realize than an object placed out of
sight was still present. Methylmercury-
exposed infants tooklonger to learn this task
than control monkeys, as well as being
retarded in the development ofthe skill of
simply reaching for an object in view. These
same infants were tested on a series of
visual recognition tasks beginning at about
1 month ofage (157,158). In this task, the
preference ofthe infant for a new stimulus,
assessed by the time spent looking at a
novel versus familiar picture, is interpreted
as being indicative of memory processes.
This test is used with human infants and is
thought to be highly predictive oflater per-
formance on intelligence tests during child-
hood. Methylmercury-exposed infant
monkeys were impaired on this task. Blood
levels of the mothers in the lowest dose
group were 1.1 ppm, with infant levels of
1.0 ppm at birth. This group ofmonkeys
exhibited facilitated performance on a test
ofspatial learning and memory as adults
(159). Monkeys exposed to methylmercury
from birth to 7 years, or in utero to 4 years
of age, exhibited no impairment in their
ability to learn the complex tasks required
for testing ofsensory system function.
In a collaborative study involving six
laboratories in the United States, the effects
of 2.0 or 6.0 mg/kg ofmethylmercury in
rats administered on gestational days 6 to 9
were studied on negative geotaxis, olfactory
orientation, auditory startle habituation,
activity, activity following a pharmacologic
challenge, and a visual discrimination task
(160). Facilitation ofauditory starde at the
high dose of methylmercury was reliably
observed across laboratories with inconsis-
tent or minimal effects on activity, pharma-
cologic challenge, and the discrimination
task, in the presence ofovert signs such as
decreased weight gain and delayed develop-
mental landmarks. Additional research
with a different battery oftests using a sub-
set of the rats from the U.S. collaborative
study revealed delayed righting and swim-
ming ontogeny and decreased activity
(161). Impairment was also observed on
performance in a complex water maze, a
task heavily dependent upon intact motor
function. Most effects were observed only
at the high dose.
In a collaborative study in Europe, rat
dams were exposed to methylmercury in
drinking water during pregnancy and lacta-
tion. Delayed sexual maturity and impaired
righting and swimming ability were
observed in the offspring (162). Assessment
ofcomplex learning measured byvisual dis-
crimination reversal and spatial delayed
alternation performance revealed increased
response latencies and an increased inci-
dence offailure to respond during a trial
with no effect on accuracy ofperformance
(163,164). In addition, the pattern of
locomotor behavior in a complex activity
monitor differed between control and
methylmercury-treated offspring, with
treated rats exhibiting less behavioral diver-
sity. In a follow-up study involving five
European laboratories, dams were exposed
to methylmercury in doses of 0.0025 to
5.0 mg/kg/day on days 6 to 9 ofgestation
(165). This study in general confirmed
results ofthe previous study with respect to
the lack of effect on accuracy ofperfor-
mance in the visual discrimination and
delayed alternation tasks. Methylmercury-
treated offspring exhibited delayed vaginal
opening, impaired swimming behavior,
decreased locomotor activity, increased
amplitude in auditory startle, and decreased
activity on a variety of end points in the
learning tasks. Most effects were observed
onlyat the highest dose, butimpaired swim-
ming ability, increased auditory startle, and
failure to respond on a spatial alternation
task were observed at 0.5 mg/kg. Delayed
vaginal opening was observed at 0.025
mg/kg, the lowest dose at which an effect
was observed.
In another study in which methylmer-
cury was used to validate a test battery,
dams were dosed on days 6 to 15 with 1, 2,
or 6 mg/kg ofmethylmercury (166). No
effects were observed on T-maze alterna-
tion, locomotor activity, amplitude or
habituation of auditory startle, observa-
tional assessment, or olfactory discrimina-
tion at the lowest two doses. (The highest
dose was lethal.)
The effects ofmethylmercury on inter-
mittent schedules ofreinforcement have also
been studied. Monkeys exposed in utero
plus postnatally, discussed above, displayed
a pattern of response on a fixed interval
schedule that suggested a decreased ability
to discriminate time (167). Rats prenatally
exposed to methylmercury were found to
exhibit retarded acquisition ofa lever-press
response, with more responses during extinc-
tion than control rats (168); this suggests
impairment ofinhibitory mechanisms in
methylmercury-treated rats. In a pair of
studies specifically designed to be sensitive
to the known effects of methylmercury
neurotoxicity in the rodent, rat dams were
gavaged with methylmercury on days 6 to 9
of gestation at doses between 0.005 and
0.50 mg/kg (169,170). Offspring were
impaired in their ability to perform on a
DRH schedule ofreinforcement in which a
number of responses on a lever were
required in a specified (short) period of
time. Methylmercury-treated offspring per-
formed normally when required to press a
lever twice within 1 sec to be reinforced
[differential reinforcement of high rate
(DRH) 2/1] but not when the response
requirement was incrementally increased to
DRH 4/2 and then DRH 8/4. Both male
and female rats were reliably affected at a
dose of 0.01 mg/kg, the lowest dose at
which effects have been observed in
rodents. The robust effects observed on this
paradigm may be the result of motor
impairment, although cognitive deficits or
decreased motivation also may have con-
tributed to the poorer performance of the
treated rats. Squirrel monkeys exposed dur-
ing the last half of gestation to variable
doses ofmethylmercury were found to be
impaired on an intermittent schedule of
complex learning at 5 to 6 years of age
(171). Monkeys were free to respond on
two levers, which were programmed to
deliver reinforcement at different densities
(i.e., one lever was richer than the other).
The behavior ofcontrol monkeys was sensi-
tive to the difference in reinforcement densi-
ties between the two levers while that ofthe
methylmercury-treated monkeys was not.
It is clear that the most salient effect of
methylmercury exposure in animals is
impairment of motor and sensory func-
tion. In the rodent, motor deficits were
reliably observed as a result ofdevelopmen-
tal exposure. Prenatal exposure in the mon-
key replicates the cerebral palsy observed in
humans exposed to high doses. At lower
doses, developmental exposure produced
deficits in all sensory systems examined-
visual, auditory, and somatosensory (vibra-
tion). The effects on cognitive function are
less clear. In rodents, results were largely
negative or showed a weak high-dose effect.
In the monkey, deficits were observed dur-
ing infancy as a result of in utero exposure;
effects during adulthood, as a result ofeven
relatively long-term developmental expo-
sure, failed to reveal deficits on most tasks,
although intermittent schedules may be sen-
sitive to methylmercury-induced alterations
in behavior. In general, the results from the
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animal literature are in good agreement with
effects in humans in which sensory and
motor deficits are also the most prominent




The main exposure route to methylmercury
in the general population is through con-
sumption ofcontaminated fish. There are
sufficient data on the neurotoxic effects of
methylmercury from episodes of human
poisoning, particularly data from the Iraqi
episode, to reasonably estimate the intake
associated with specific adverse effects
(100). For adults, an intake of 50 pg per
person per daywould result in a 0.3% inci-
dence ofparesthesias; an intake of 3 to 7
pg/kg ofmercury per day would result in a
5% incidence ofeffects in the adult popu-
lation. The current U.S. Environmental
Protection Agency (U.S. EPA) RfD is 0.3
jig/kg/day based on paresthesia in adults.
However, the developing fetus is affected at
a threshold one-fifth ofthat at which effects
occur in the mother, or 0.6 to 1.4 pg/kg of
mercury per day to the mother. [In fact,
there may not be a threshold (100).]
Assumption of a safety factor of 10 for
intraspecies variability would result in an
allowable intake of 0.06 to 0.14 pg/kg of
mercury per day. In the monkey, neurotox-
icity was reliably detected as a result of in
utero or postnatal exposure to 50 pg/kg/day.
(Neurotoxicity was also apparent at 10 or 25
pg/kg/day, but the total sample consisted of
onlythree monkeys.) Assuming a safety fac-
tor of 1000 for extrapolation between
species, individual variability and the fact
that 50 pg/kg/day is a LOAEL rather than a
NOAEL would result in an allowable
intake in humans of0.05 pg/kg/day, which
is consistent with the estimates from the
human data. The most sensitive study in
rats in which a LOAEL of0.01 mg/kg and
a NOAEL of0.005 mg/kg were identified
would also yield an RfD of0.05 pg/kg/day.
In an extensive review of the human data,
Stern (172) suggested an RfD of 0.07
pg/kg ofmercury per day to protect against
developmental toxicity. The U.S. EPA
Office ofWater derived an RfD of 0.06
pg/kg/day in a draft document. Both of
these calculations are based on the Iraqi
studies demonstrating neurologic signs or
delayed walking in infants born to mothers
consuming methylmercury. Gilbert and
Grant-Webster (173) suggested an RfD of
0.025 to 0.06 pg/kg/day based on both the
epidemiologic and animal data.
The estimates of fish intake that have
been used to estimate risk to various popu-
lations vary widely. For example, the U.S.
EPA (174) estimated the 50th percentile
intake for recreational anglers to be 30
g/day, with the 90th percentile at 140
g/day. Bolger et al. (175) estimated intakes
at 13 g/day and 26 to 40 g/day for the 50
and 90th percentiles, respectively, for fish
caught by recreational anglers, based on the
assumption that one fishing trip results in
the consumption of 8 oz of fish. Current
Canadian guidelines assume an intake of20
g offish per day for the general population
and 40 g/day for frequent fish eaters. The
Market Research Corporation ofAmerica's
1982 to 1987 14 Day Menu Census IV
study (176) reported a mean intake of32
g/day and a 90th percentile of64 g/day for
the fish-eating portion ofthe population.
Stern (172) performed a Monte Carlo
analysis based on these latter intake esti-
mates and levels ofmercury in fish intended
for human consumption published by the
National Marine Fisheries Service. In that
analysis, 52% ofthe fish had total mercury
levels <0.05 pg/g and 5% ofthe catch had
mercury levels <0.25 pg/g. Stern con-
cluded that a substantial proportion of
women (23%) would exceed a maximum
allowable intake based on an RfD of0.07
pg/kg/day, and 0.5% ofwomen would
exceed the 7 pg/kg/day intake demonstrated
to cause in uterodevelopmental effects.
Assuming an RfD of 0.07 pg/kg/day,
methylmercury consumption should not
exceed about 4 pg/day for a 62-kg woman.
An intake of 20 g of fish per day, the
Canadian estimate for the general popula-
tion, would yield maximum allowable lev-
els in fish of 0.30 pig/g. An intake of 64
g/day, the 90th percentile based on the
Market Research Corporation data and
used by Stern in his analysis, would yield a
maximum allowable level of mercury in
fish of 0.06 pg/g. Mercury levels in Great
Lakes fish routinely exceed even the higher
of these numbers. For example, in a survey
ofwalleye in northern Wisconsin Lakes in
1990 to 1991, 45% had levels greater than
0.5 pg/g (177). Data from 1991 from the
Canadian Department of Fisheries and
Oceans for commercial fish intended for
human consumption taken from the four
Great Lakes bordering Canada revealed
levels averaging 0.14 to 0.32 pg/g depend-
ing on location and fish species (including
piscivorous and nonpiscivorous fish)
(unpublished data). The average for the
entire sample ofover 400 fish was 0.23 pg/g.
There are significant gaps in the data
required for a definitive analysis of the
proportion ofwomen ofchildbearing age
who may be considered at risk as a result of
consumption of Great Lakes fish. Among
these are the distribution ofthe amount of
Great Lakes fish consumed, particularly for
individuals or groups consuming large
amounts offish; the pattern of species of
fish consumed by individuals; the geo-
graphical source of the fish; and other
sources ofmethylmercury exposure such as
tuna or shark. Nonetheless, the data
presendy available suggest that consumption
of Great Lakes fish represents a potential
hazard to offspring ofwomen consuming
large quantities offish.
Polychlorinated Biphenyls
Polychlorinated biphenyls are a family of
chemicals containing 209 different isomers
(congeners). Their major usewas as a dielec-
tric in transformers and capacitors, although
they had other industrial uses as well. They
were in widespread use from the 1930s
until the 1970s; they are presently a world-
wide pollution problem because they are
resistant to either chemical or biologic
degradation and they (like methylmercury)
accumulate in the food chain. It is clear
from both the animal literature and human
epidemiologic studies that the developing
organism is more sensitive to behavioral
deficits produced by PCBs than the adult.
At least two prospective studies have been
published that assess the relationship
between PCB exposure and adverse effects
in infants, which have been critically
reviewed (178,179). There is also a recent
review ofthe animal literature with respect
to developmental toxicity associated with
PCBs (179). Several studies have been per-
formed in monkeys at the University of
Wisconsin on the reproductive effects and
later behavioral consequences in the off-
spring ofexposure to PCB mixtures. Studies
in rodents have also revealed behavioral
impairment as a result ofdevelopmental
exposure to PCBs. The following sections
provide a briefreview ofthe literature, with
emphasis on body burdens at which effects
were observed.
HumanEpidemiologicStudies
In 1968 a tragic epidemic inJapan occurred
as a result ofcontamination of rice oil with
PCBs and small amounts ofother contami-
nants (180). Infants born to mothers who
consumed the contaminated oil had dark
pigmentation ofthe skin, low birth weight,
early eruption of the teeth, and swollen
gums and eyelids. In another incident in
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Japan, affected children had hypotonic
reflexes, were dull and apathetic, and had
low IQs (181). Children born after a simi-
lar incident in Taiwan were followed for at
least 6 years (182). These children exhib-
ited delayed developmental milestones and
deficits on the Bayley, WISC, and Rutter
scales. These effects were observed at expo-
sure levels that produced overt signs
including gum hypertrophy, deformed or
pigmented nails, acne, hyperpigmentation,
and hair loss. In addition, these children
were also exposed concurrently to more
toxic polychlorinated dibenzofurans.
An extensive prospective study involved
Michigan children born to women who
consumed fish from Lake Michigan
(183-190). Reduction in birth weight, head
circumference and gestational age were asso-
ciated with consumption ofcontaminated
fish. Fish consumption in the mothers was
also associated with lower scores on the
Brazelton Neonatal Behavioral assessment in
the infants. Decreased visual recognition
memory in this same set of infants at 7
months of age was associated with both
maternal fish consumption and cord serum
PCB levels (186). Visual recognition mem-
ory has been shown to be highly predictive
ofperformance on later tests ofintelligence
(191-194). There was no association with
postnatal exposure through nursing, and
there was no association between poly-
brominated biphenyl (PBB) levels and out-
come in these infant studies. This cohort
was tested again at 4 years ofage; cord PCB
levels were associated with decreased
weight (188) and poorer short-term mem-
ory (Figure 6) (189). These measures were
not associated with concurrent blood levels
of PCBs, PBBs, lead, or dichlorodiphenyl-
trichloroethane (DDT). (A number ofother
possible contaminants were not detected in
blood.) Hypoactivity was associated with
concurrent blood PCB levels (188).
A cohort of breast-fed infants was fol-
lowed prospectively for 60 months in a
North Carolina study (195-197). Mothers
had no known excessive exposure to PCBs.
Higher in utero PCB exposure as assessed
by maternal milk fat PCBs was associated
with hypotonicity and hyporeflexia on the
Brazelton Neonatal Behavioral Assessment;
there was no association with birth weight
or head circumference (198). Higher
transplacental but not postnatal PCB expo-
sure was associated with lower Bayley Scale
scores at 6 and 12 months of age (195).
There was no association between either
prenatal or concurrent PCB levels and a
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Figure 6. Adjusted McCarthyVerbal scale scores (A) and
McCarthy Memory scale scores (B) at 4years of age as a
function of maternal blood PCB levels. Group sample-size
numbersare in parentheses. FromJacobson etal. (189).
ofChildren's Ability at 3 to 5 years ofage.
Dichlorodiphenyldichloroethane (DDE)
levels were also measured in this study and
were largely unrelated to outcome variables.
The most sensitive indicator of neuro-
toxicity was a deficit in visual recognition
memory in infants in the Michigan study.
Tilson et al. (179) estimated the NOAEL,
by visual inspection ofthe data, to be 1.0
ppm PCB in the fat ofbreast milk. They
assumed a 60-kg woman with 25% fat to
derive a daily intake of 0.027 pg/kg/day;
this would result in a 1.0-ppm level in milk
fat, which they assumed to be equivalent to
the level in body fat. The human RfD
derived was therefore 2.7 x 10-3 pg/kg/day.
Animal Studies
Manyofthe same or similar effects observed
in the human epidemiologic studies have
been observed in animal studies, particularly
in monkey studies performed at the
University ofWisconsin. Two series of
experiments were performed: one with
Arocler 1248 and the other with Aroclor
1016; both experiments were developmental
studies. In general, offspring were exposed
in utero and through breast milk until 4
months ofage. Reproductive outcome was
assessed and the offspring underwent exten-
sive behavioral testing into adulthood.
In the Aroclor 1016 study, adult females
were exposed to 0, 0.25, or 1.0 ppm PCBs
in the diet (199,200), which corresponded
to approximately 0.007 and 0.028 mg/kg
body weight (bw) per day for the low- and
high-dose groups, respectively. Birth weight
ofthe infants was significantly reduced in the
high- but not the low-dose group (201),
with no difference in head circumference or
crown-to-rump length. Overt signs in the
form ofhyperpigmentation were present in
both groups of infants. Behavioral assess-
ment was first performed when offspring
were 14 months old (199,200); high-dose
monkeys were impaired on a spatial dis-
crimination reversal task. This same group
ofmonkeys was tested on a spatial delayed
alternation task (a spatial learning and
short-term memory task) at 4 to 6 years of
age (200,202). Neither group was different
from controls, although the high-dose
group was impaired relative to the low-
dose group. This was due to a slightly
improved performance of the low-dose
group and slightly impaired performance of
the high-dose group relative to controls.
These data yield a NOAEL of0.7 x 10-2
mg/kg/day based on learning and memory
impairment and infant birth weight, and
consideration offetotoxicity and chloracne
results in a LOAEL of0.7 x 10-2 mg/kg/day
with no NOAEL.
In the Aroclor 1248 studies, females
were exposed to 0, 0.5, or 1.0 ppm PCBs
in the diet 3 days per week beginning
before breeding and continuing until off-
spring were weaned at 4 months of age.
Additional groups offemales were exposed
to 2.5 ppm either concurrent with breed-
ing, or in which exposure ceased 1.0, 1.5,
or 3.0 years before breeding; these females
produced a number of sets ofoffspring.
Concurrent exposure to 2.5 ppm resulted in
reduced birth weight (203) and deficits in
discrimination-reversal learning (204).
These monkeys were hyperactive when
young (204) and hypoactive at 44 months
ofage (205). Monkeys exposedconcurrently
to 0.5 ppm were hyperactive at 12 months
of age (206). The group born to mothers
1.0 year after cessation ofexposure to 2.5
ppm showed facilitated performance on a
shape discrimination-reversal task (199),
which the authors interpreted as a deficit in
the treated group's ability to learn the
irrelevance ofthe shape cue on a previous
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task. The performance ofthe 1.0 ppm group
was not impaired on this task. Monkeys
born to mothers 1.5 or 3.0 years after ces-
sation of exposure to 2.5 ppm PCBs were
impaired on a spatial alternation task at 4
to 6 years ofage (200).
The concentrations in the feed of 0.5,
1.0, and 2.5 ppm represent approximate
intakes of 0.008, 0.016, and 0.089
mg/kg/day, respectively. (Mothers exposed
to 2.5 ppm ingested about 290 mg [0.63
mg/week] of PCBs over 86 to 89 weeks;
mothers exposed to 1.0 ppm ingested 7.5
mg/kg over 16 months.) It is difficult to
establish RfDs from these data since infants
born as long as 3.0 years after maternal
exposure to 2.5 ppm exhibited impaired
learning; the exposure levels of this cohort
are unknown. However, the most sensitive
effect in a concurrently exposed group was
hyperactivity observed in the 0.5-ppm group
at 1 year ofage. The RfD derived from this
end pointwould be 8 x 10-3 pg/kg/day.
There is a relatively large body ofdata
on the effects of developmental toxicity of
PCBs in the rodent, which focuses on neu-
rotoxicity (179) or developmental end
points (207). Tilson et al. (179) concluded
that the most consistently observed effect
across species was hyperactivity, although
cognitive deficits were also observed in
rodents as well as in monkeys. It is clear
that the rodent is less sensitive than the
monkey or human; Tilson et al. (179)
derive RfDs from the rodent data two
orders of magnitude higher than those
based on monkey data.
The human and animal data are in
good agreement with respect to the types
ofdeficits observed. The monkey, like the
human, develops chloracne and hyperpig-
mentation as a result ofdevelopmental PCB
exposure. Changes in neuromotor function
were consistently observed in both rodent
and monkey studies. In both the Michigan
and North Carolina studies, the Brazelton
assessment revealed abnormally weak
reflexes and deficient fine motor control.
Both human and animal studies revealed
cognitive deficits. In particular, the memory
deficits observed on the visual recognition
task in the Michigan study are consistent
with the impairment of memory and
attention observed in monkeys. The human
studies are problematic in that exposure
through fish also potentially resulted
in exposure to other neurotoxic agents
correlated with PCB levels in contaminated
fish. While some of these potential con-
founders were assayed in the Michigan
studies, the failure to determine methylmer-
cury levels is a potentially serious weakness.
However, the congruence between the
monkey and human data suggests that the
deficits observed in the human studies
result at least in part from PCB exposure.
Contribution from
GreatLakes Sources
The U.S. EPA has derived an RfD for
Aroclor 1016 of 0.07 pg/kg bw per day
from the monkey data (208) based on a
NOAEL for reduction in birth weight of
7.0 pg/kg bw per day (0.25 ppm in feed)
(197-200) and an uncertainty factor of
100. Tilson et al. (179) have calculated a
LOAEL from the 1248 monkey studies of
14 pg/kg bw per day based on behavioral
data; there was not a NOAEL. The recom-
mended RfD derived from these data was
0.014 pg/kg bw per day. Based on the cal-
culations in the above section, the RfD
based on the observed hyperpigmentation
in the Aroclor 1016 monkey study would
be 0.007 pg/kg/day, and for the 1248
study, it would be 0.008 pg/kg/day.
Tilson et al. (179) derived a NOAEL
for humans of 0.027 pg/kg/day based on
impaired visual recognition memory in
infants in the Michigan study. However,
some of the assumptions upon which this
calculation was based have been criticized
[e.g., Great Lakes Sport Fish Advisory Task
Force (GLSFATF) (209)], particularly the
assumption that there is no metabolism or
excretion of PCBs. Estimates ofhalf-lives
in humans (not necessarily women) range
from 1.8 years to 9.9 years (210-212),
depending on which commercial mixture
or congener is considered. Estimates for
congener 153, the most common congener
found in Lake Michigan anglers (209), is
5.4 to 9.9 years (213). Assuming a half-life
of 1 year yields a NOAEL based on visual
recognition memory of 0.475 pg/kg/day,
while assumption of a 10-year half-life
results in a NOAEL of 0.0475 pg/kg/day
(209). Therefore, these various estimates
would yield an RfD between 0.0027 and
0.0475 pg/kg/day depending on assump-
tions concerning degree ofmetabolism.
The Agency for Toxic Substances and
Disease Registry (214) derived a mini-
mum risk level (similar to an RfD) of
0.005-pg/kg/day based on immune effects
in monkeys. The Tennessee Valley
Authority developed an RfD of 0.05
pg/kg/day, and the Ohio River Valley
Sanitation Commission (215) derived an
RdD of0.1 pg/kg/day for low chlorinated
PCBs such as Aroclor 1016 or 1242 and
an RfD of0.01 pg/kg/day for more highly
chlorinated PCBs such as Aroclor 1254.
The National Wildlife Federation (216)
derived an RfD of0.01 pg/kg/day based on
the behavioral data from the monkey; the
GLSFATF (209) derived an RfD of 0.05
pg/kg/day based on the behavioral data
from the Michigan epidemiologic study.
The Joint FAO (Food and Agriculture
Organization)/WHO Expert Committee
on Food Additives (217) did not establish
a value for tolerable intake in humans; they
concluded that 0.04 mg/kg/day was a no-
effect dose based on the monkey studies.
Assuming an RfD of0.01 pg/kg/day, a
90th percentile intake of 64 g/day of fish
would yield an allowable level in fish of
approximately 0.01 pg/g, and an RfD of
0.05 pg/kg/day would yield a value of
approximately 0.05 pig/g. The Lake Ontario
Toxics Management Plan (218) reported
levels in coho salmon from the Credit River
in 1988 of 1 pg/g; levels in lake trout in the
same year were >3 pg/g. De Vault (219)
reported PCB levels in lake trout in Lake
Superior to be <0.5 pg/g, while levels in
Lake Michigan were >2.5 pg/g; they
reported that levels over the last few years
appear to have stabilized after decreasing for
more than a decade. According to a docu-
ment from the State of the Great Lakes
conference (220), PCB levels in walleye in
Lake Erie increased between 1989 and
1992 to levels of over 2 pg/g. The GLS-
FATF (209) reported that the average PCB
levels in coho salmon in Lake Michigan are
currently 0.8 pg/g. Data from the Canadian
Department of Fisheries and Oceans for
1991, based on approximately 450 samples
of Great Lakes fish including piscivorous
and nonpiscivorous fish, revealed an average
PCB level of 1.38 pg/g. Similar levels were
found in a recent independent analysis of
commercial Great Lakes fish (221). It is
apparent that PCB levels at many sites are
considerably higher than recommended lev-
els based on the RfDs derived by a number
of agencies and, in fact, are well into the
range that may be expected to produce
developmental neurotoxicity.
Environmental Health Perspectives
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